Dentsply International Inc. (XRAY) Short Interest Update
Dentsply International Inc. (NASDAQ:XRAY) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 8,288,029 shares, an increase of 28.1% from the September 15th total of 6,471,038 shares. Approximately 3.6% of the shares of the stock are sold short. Based on an average trading volume of 1,480,437 shares, the days-to-cover ratio is presently 5.6 days.
In other news, VP Rainer Berthan sold 5,000 shares of the company’s stock in a transaction on Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total transaction of $305,600.00. Following the completion of the sale, the vice president now directly owns 34,370 shares in the company, valued at approximately $2,100,694.40. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Maureen J. Macinnis sold 45,100 shares of the company’s stock in a transaction on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total value of $2,730,805.00. Following the sale, the senior vice president now owns 36,730 shares of the company’s stock, valued at $2,224,001.50. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. Creative Planning increased its position in shares of Dentsply International by 41.7% in the third quarter. Creative Planning now owns 5,774 shares of the company’s stock worth $343,000 after buying an additional 1,699 shares during the period. Reilly Herbert Faulkner III boosted its stake in Dentsply International by 2.6% in the third quarter. Reilly Herbert Faulkner III now owns 67,691 shares of the company’s stock worth $4,023,000 after buying an additional 1,744 shares in the last quarter. Contravisory Investment Management Inc. boosted its stake in Dentsply International by 8.9% in the third quarter. Contravisory Investment Management Inc. now owns 3,108 shares of the company’s stock worth $185,000 after buying an additional 254 shares in the last quarter. First Mercantile Trust Co. boosted its stake in Dentsply International by 18.6% in the third quarter. First Mercantile Trust Co. now owns 65,994 shares of the company’s stock worth $3,922,000 after buying an additional 10,347 shares in the last quarter. Finally, Telemus Capital LLC boosted its stake in Dentsply International by 0.4% in the third quarter. Telemus Capital LLC now owns 7,852 shares of the company’s stock worth $467,000 after buying an additional 35 shares in the last quarter. Institutional investors and hedge funds own 94.58% of the company’s stock.
Shares of Dentsply International (NASDAQ:XRAY) opened at 57.82 on Friday. Dentsply International has a 1-year low of $53.43 and a 1-year high of $65.83. The stock has a 50 day moving average price of $59.86 and a 200 day moving average price of $61.32.
Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings data on Friday, August 5th. The company reported $0.76 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.70 by $0.06. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The business earned $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the firm posted $0.73 earnings per share. The business’s revenue for the quarter was up 46.4% compared to the same quarter last year. Equities analysts forecast that Dentsply International will post $2.76 EPS for the current year.
The company also recently disclosed a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a $0.0775 dividend. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s dividend payout ratio (DPR) is currently 14.49%.
XRAY has been the subject of several recent analyst reports. Bank of America Corp. initiated coverage on Dentsply International in a research report on Monday, September 12th. They set a “buy” rating and a $70.00 price objective for the company. JPMorgan Chase & Co. initiated coverage on Dentsply International in a research report on Thursday, September 22nd. They set a “neutral” rating and a $65.00 price objective for the company. Zacks Investment Research downgraded Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Piper Jaffray Cos. restated a “buy” rating on shares of Dentsply International in a research report on Monday, June 27th. Finally, Barrington Research downgraded Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $66.91.
About Dentsply International
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.